ROMANO KATHRYN
Chief Accounting Officer
ROMANO KATHRYN has filed 2 SEC Form 4 filings (14 transaction rows) across 1 company, with disclosures dating back to 2026. 2 of those filings fall inside the rolling window. Most recent filing: Mar 3, 2026.
On the most recent filing, ROMANO KATHRYN is listed as Chief Accounting Officer at Krystal Biotech, Inc. Inside the rolling window, ROMANO KATHRYN reported no open-market purchases and 2 open-market sales totaling $3.6M in KRYS. The largest disclosed transaction in the window is a sale of 12,500 KRYS shares on Feb 9, 2026, worth $3.4M.
Companies traded
Other insiders at KRYS
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$3.6M
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has ROMANO KATHRYN made?
ROMANO KATHRYN has filed 2 SEC Form 4 filings (14 transaction rows) across 1 company since 2026.
Which companies does ROMANO KATHRYN trade?
ROMANO KATHRYN has filed SEC Form 4 disclosures for 1 company, including KRYS.
When was ROMANO KATHRYN's most recent SEC Form 4 filing?
ROMANO KATHRYN's most recent SEC Form 4 filing on Tracefour is dated Mar 3, 2026.
What is ROMANO KATHRYN's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, ROMANO KATHRYN is listed as Chief Accounting Officer.
What is ROMANO KATHRYN's total buy and sell value in the current window?
Inside the rolling retention window, ROMANO KATHRYN bought $0 and sold $3.6M based on SEC Form 4 filings.
What was ROMANO KATHRYN's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 12,500 KRYS shares on 2026-02-09, worth $3.4M, per SEC Form 4 filings.